T1	SNP 2 17	genetic variant
T2	Entity 29 36	miR-423
R1	SNP_coupled_gene Arg1:T1 Arg2:T2	
T3	Association 40 50	associated
E1	Association:T3 snp_int:T1 bc:T5
A1	Effect_Type E1 Decrease
T4	Effect_Type 56 63	reduced
R2	Effect_type_marker Arg1:E1 Arg2:T4	
T5	Cancer 64 77	breast cancer
T6	SNP 323 332	rs6505162
T7	Entity 341 346	A > C
R3	Nucleotide_substitution Arg1:T6 Arg2:T7	
T8	Spec 295 303	examined
T9	Entity 375 391	pre-miRNA region
T10	Entity 395 402	miR-423
R5	SNP_location Arg1:T6 Arg2:T9	
R6	SNP_coupled_gene Arg1:T6 Arg2:T10	
T11	Cancer 407 420	breast cancer
T12	Association 421 432	development
E2	Association:T12 bc:T11 snp_int:T6
R7	Speculation_marker Arg1:E2 Arg2:T8	
T13	Entity 434 460	Caucasian Australian women
T14	SNP 542 551	rs6505162
R9	Population_assignment Arg1:T14 Arg2:T13	
R8	Equiv Arg1:T6 Arg2:T14	
T16	Entity 767 769	CC
T17	SNP 542 551	rs6505162
R10	Genotype Arg1:T17 Arg2:T16	
T15	Effect_Type 790 797	reduced
T18	Association 798 802	risk
E3	Association:T18 bc:T19 snp_int:T17
A2	Effect_Type E3 Decrease
T19	Cancer 806 819	breast cancer
R4	Effect_type_marker Arg1:E3 Arg2:T15	
R11	Member Arg1:T6 Arg2:T17	
R12	Equiv Arg1:T1 Arg2:T17	
